Stem cells injected into artery to fight severe colitis
NCT ID NCT04312113
First seen Jan 29, 2026 · Last updated May 13, 2026 · Updated 17 times
Summary
This early-phase study tests whether delivering a person's own fat-derived stem cells directly into an artery is safe for treating moderate to severe ulcerative colitis. About 20 adults aged 18-65 who have not responded to at least two standard medications will receive the treatment. The main goal is to check for side effects, and researchers will also look for signs of bowel healing and symptom improvement.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.